Skip to content
R

Rufina Soomro

0000-0002-5876-8894

Publications (4)

Performance of TyrerCuzick Model for Breast Cancer Risk Assessment among Pakistan’s Females

Rufina Soomro & Rabia Niaz · Journal of Advances in Medicine and Medical Research · 2021

Background: Breast cancer incidence is highest in Pakistan among Asian countries. The known risk factors are family history, hormonal exposure, benign proliferative diseases, and high mammographic density which are included in the TyrerCuzick model. The model needs validation stu...

Open access Research Article 10.9734/jammr/2021/v33i2331188

Impact of Surgery in De Novo Metastatic Breast Cancer after Systemic Disease Control

Rufina Soomro, Afsheen Javaid Khokher & Naila Zahid · Journal of Advances in Medicine and Medical Research · 2021

Background: Systemic chemotherapy is the standard of care for patients with metastatic breast cancer, with an undecided role in surgery. Limited data is available for the role of surgery on the overall survival of stage 4 breast cancer regarding luminal subtypes of patients. This...

Open access Research Article 10.9734/jammr/2021/v33i2231167

Association of Neutrophil to Lymphocyte Ratio with Clinicopathological Features in Breast Cancer

Rufina Soomro & Namiya Cho · Journal of Advances in Medicine and Medical Research · 2021

Background: Even with the advances in the diagnosis and treatment of breast malignancy, to date breast cancer is still the number one cause of death in women in Pakistan. Various researches proved that prolonged inflammatory conditions played a part in progression of malignancy,...

Open access Research Article 10.9734/jammr/2021/v33i1430975

Clinicopathologic Predictors of Pathologic Complete Response after Neoadjuvant Systemic Therapy and Impact on Surgical Management

Rabia Niaz & Rufina Soomro · Journal of Advances in Medicine and Medical Research · 2022

Neoadjuvant systemic therapy previously given for inoperable breast cancer is increasingly being administered in early breast cancer especially in triple negative and HER2 positive molecular subtypes. It is associated with an increased rate of complete pathologic response (PCR) w...

Open access Research Article 10.9734/jammr/2022/v34i331269